Your session is about to expire
← Back to Search
Chemotherapy for Leukemia and Lymphoma
Study Summary
This trial is testing different combinations of chemotherapy drugs to treat patients with newly diagnosed standard-risk acute lymphoblastic leukemia or B-lineage lymphoblastic lymphoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 4 trial • 122 Patients • NCT01474915Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had chemotherapy for my current B-ALL/B-LLy or any cancer before starting the AALL0932 protocol, except for steroids or intrathecal cytarabine.Your white blood cell count at the start of the study should be less than 50,000 cells per microliter.I am not pregnant or have a negative pregnancy test if of childbearing age.I am using effective birth control during the study.I am currently pregnant.I have been newly diagnosed with a specific type of leukemia and may have Down syndrome.My leukemia has spread to my brain or spinal cord.My leukemia has spread to my brain/spinal cord or testicles.My leukemia involves a specific range of immature blood cells.
- Group 1: Arm A (risk-adapted chemotherapy)
- Group 2: Arm B (risk-adapted chemotherapy)
- Group 3: Arm B-LLy (4-week cycle maintenance)
- Group 4: Arm C (risk-adapted chemotherapy)
- Group 5: Arm D (risk-adapted chemotherapy)
- Group 6: Arm LR-C (risk-adapted chemotherapy)
- Group 7: Arm LR-M (risk-adapted chemotherapy)
- Group 8: Arm SR DS (12-week cycle maintenance)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what sorts of medical issues is Dexamethasone generally prescribed?
"Dexamethasone is a common medication used to treat pheochromocytomas. Additionally, this medication can be used to manage other conditions such as ulcerative colitis, certain types of viral eye infections, and varicella-zoster virus acute retinal necrosis."
Is this medical study novel in terms of its approach or treatments?
"Currently, 2036 different clinical trials testing Dexamethasone are ongoing in 88 countries and 3496 cities. The first such trial began in 1997 and, sponsored by Alfacell, completed its Phase 3 drug approval stage with 300 participants. In the years since 1997, 4265 Dexamethasone trials have been conducted."
How many separate places are coordinating this experiment?
"The trial is based out of AdventHealth Orlando in Orlando, Florida, Yale University in New Haven, Connecticut, El Paso Children's Hospital in El Paso, Texas; as well as 100 other sites."
Are there any positions available in this research project for participants?
"The clinical trial in question is not presently looking for new patients, however, this may change in the future. The original posting date was 8/9/2010, with the most recent edit on 7/8/2022. Although this study is not recruiting candidates at this time, there are 5036 other studies presently accepting participants."
If I take part in this experiment, will I be able to complete it?
"Eligibility requirements for this clinical trial include having down syndrome and being between 1 and 30 years old. The total number of participants that the study is hoping to recruit is 9350 individuals."
Are people of legal age welcome in this research project?
"This trial is for patients aged 1 year to 30 years old. Out of 4251 trials for patients over 65 and 1129 trials for those under 18, this is the only study that meets the specified age range."
Has Dexamethasone undergone drug trials by the FDA?
"Dexamethasone has received a rating of 3 from our team at Power. This means that, while it is a phase 3 trial medication, there is some data supporting its efficacy as well as multiple rounds of data supporting its safety."
Are there any other papers which mention Dexamethasone?
"The first documented use of dexamethasone was in 1997 at Spectrum Health Hospital - Butterworth Campus. In the years since, 4265 similar studies have been completed with 2036 currently active. A large number of these active studies are based in Orlando, Florida."
Share this study with friends
Copy Link
Messenger